Unilateral pallidothalamic tractotomy for akinetic-rigid Parkinson’s disease: a prospective open-label study
- 1 September 2021
- journal article
- research article
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 135 (3), 799-805
- https://doi.org/10.3171/2020.7.jns201547
Abstract
Neurosurgical ablation is an effective treatment for medically refractory motor symptoms of Parkinson’s disease (PD). A limited number of studies have reported the effect of ablation of the pallidothalamic tract for PD. In this study, the authors evaluated the safety and efficacy of unilateral pallidothalamic tractotomy for akinetic-rigid (AR)–PD. Fourteen AR-PD patients, who were enrolled in this prospective open-label study, underwent unilateral pallidothalamic tractotomy. The Movement Disorder Society–Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) Part III and Part IV (dyskinesia and dystonia) scores and levodopa equivalent daily dose (LEDD) were evaluated at baseline and at 3 and 12 months postoperatively. Of the 14 patients enrolled in the study, 4 were lost to follow-up and 10 were analyzed. The total MDS-UPDRS Part III score significantly improved from 45 ± 4.6 at baseline to 32.9 ± 4.8 at 12 months postoperatively (p = 0.005). Contralateral side rigidity and bradykinesia significantly improved from 4.4 ± 0.5 and 10.4 ± 1.5 at baseline to 1.7 ± 0.4 (p = 0.005) and 5.2 ± 1.4 (p = 0.011) at 12 months, respectively. While posture significantly improved with a 20% reduction in scores (p = 0.038), no significant improvement was found in gait (p = 0.066). Dyskinesia and dystonia were improved with a 79.2% (p = 0.0012) and 91.7% (p = 0.041) reduction in scores, respectively. No significant change was found in the LEDD. Hypophonia was noted in 2 patients, eyelid apraxia was noted in 1 patient, and a reduced response to levodopa, which resulted in an increase in the daily dose of levodopa, was noted in 3 patients. No serious permanent neurological deficits were observed. Unilateral pallidothalamic tractotomy improved contralateral side rigidity and bradykinesia, dyskinesia, and dystonia in patients with AR-PD. Clinical trial registration no.: UMIN000031138 (umin.ac.jp)Keywords
This publication has 18 references indexed in Scilit:
- Baseline motor findings and Parkinson disease prognostic subtypesNeurology, 2017
- Differential effects of deep brain stimulation target on motor subtypes in Parkinson's diseaseAnnals of Neurology, 2015
- Akinetic-rigid and tremor-dominant Parkinson's disease patients show different patterns of intrinsic brain activityParkinsonism & Related Disorders, 2014
- First experience with MR-guided focused ultrasound in the treatment of Parkinson's diseaseJournal of Therapeutic Ultrasound, 2014
- Differences in striatal dopamine transporter density between tremor dominant and non-tremor Parkinson’s diseaseEuropean Journal of Nuclear Medicine and Molecular Imaging, 2014
- Different patterns of nigrostriatal degeneration in tremor type versus the akinetic-rigid and mixed types of Parkinson's disease at the early stages: Molecular imaging with 123I-FP-CIT SPECTInternational Journal of Molecular Medicine, 2011
- Course in Parkinson disease subtypesNeurology, 2009
- Morphological differences in Parkinson’s disease with and without rest tremorZeitschrift für Neurologie, 2009
- Human pallidothalamic and cerebellothalamic tracts: anatomical basis for functional stereotactic neurosurgeryBrain Structure and Function, 2008
- A revival of Spiegel's campotomy: long term results of the stereotactic pallidothalamic tractotomy against the parkinsonian thalamocortical dysrhythmiaThalamus & Related Systems, 2005